- Moderate and connect: Open Platform for activities
- Foster a networking and integration platform amongst the Basel Region Life Sciences Community
- Enabling and facilitate an open network, beyond political and geographical boundaries
Matching Business Angels and Companies
BioValley matches its members with interesting life science start-ups seeking risk capital and other resources. The focus is on projects located in the Basel area and the trinational BioValley cluster in the area of biotech, pharma, diagnostics and medtech in seed or early stage. The projects/companies are selected on the base of the submitted material, the general interest of the members of BioValley Basel and the experience of the team.
Angel investments may benefit entrepreneurs through exposure to a wider set of potential investors, and a structured process that facilitates relatively quick and efficient investment decisions. Angel investing represents a large and growing portion of early stage capital available to startup companies. Business angels typically invest between CHF 50k and CHF 200k per transaction individually, and from CHF 250k to CHF 1’000k as a group. On average, angels are patient, participate in multiple capital rounds, and have an overall investment horizon of up to eight years. We expect to hold 2-3 events per year with presenting companies selected by screening process. We evaluate based on management team, market opportunity, growth potential, stage, as well as other factors.
Part of the trinational BioValley cluster
BioValley Basel is part of the trinational BioValley life sciences cluster extending in the Basel region across borders into France, Germany and Switzerland. It is the leading hot spot in Europe in life sciences and encompasses 40 scientific institutions, 900 companies (incl. 40% of the biggest pharmaceutical companies in the world), 100’000 students and more than 11 Life Science Parks. A large number of organisations support professional networking with peers from the industry. See our Network page for further detail.
- To strengthen the leading Biotech Hub of Europe
- To support existing and new companies
- To promote start-ups
- To encourage technology transfer
- To encourage new alliances
- To maintain a network with all players in the life sciences